Trials / Not Yet Recruiting
Not Yet RecruitingNCT06738745
Study of HRS-2189 Combined HRS-5041 in Prostate Cancer
A Phase II Study of HRS-2189 Combined HRS-5041 in Metastatic Prostate Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Our study is aimed to evaluate the efficacy and safety of HRS-2189 combined with HRS-5041 in metastatic prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-2189 | HRS-2189 |
| DRUG | HRS-5041 | HRS-5041 |
Timeline
- Start date
- 2024-12-31
- Primary completion
- 2027-01-31
- Completion
- 2027-08-31
- First posted
- 2024-12-18
- Last updated
- 2024-12-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06738745. Inclusion in this directory is not an endorsement.